The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis (NCT05356793) | Clinical Trial Compass
CompletedPhase 2
The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
United States30 participantsStarted 2021-03-01
Plain-language summary
The objective of this study is to evaluate the efficacy of Sasch1, a novel anti-infective eyedrop, in the treatment of acute infectious conjunctivitis.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Conjunctivitis (as defined below) within 72 hours of initial ocular symptoms.
* At least 18 years of age.
* Subjects capable of understanding the purpose and risks of the study, and able to give informed consent.
* Conjunctivitis diagnosis defined as presence of the two cardinal signs of acute conjunctivitis- 1) bulbar conjunctival injection and 2) conjunctival discharge/exudates.
* A three-point rating scale (0=absent, 1=mild, 2=moderate, 3=severe) will be employed to grade conjunctival discharge/exudates.
* All patients will require a rating of 1(mild) or greater for conjunctival discharge/exudates.
* Patients will require a rating of 1 (mild) for bulbar conjunctival injection.
Exclusion Criteria:
* Conjunctivitis greater than 72 hours after initial ocular symptoms
* Corneal ulcer, endophthalmitis, or any other confounding infection of the eye
* Patients taking topical anti-inflammatory medications on a chronic basis
* Known steroid glaucoma responders
* Active herpes ocular infection
* Pregnant women
* Known allergy to chlorhexidine
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.